InvestorsHub Logo

SPecPrototype

02/28/20 12:59 PM

#33760 RE: Releasemas #33759

Agreed. However a major first step seems to have commenced and revenues will be generated with which i think is key.

midas716

02/28/20 1:25 PM

#33765 RE: Releasemas #33759

Please point out the "previous GCAN discussions"

especially since gcan said they can produce xx number of patches per month. They did not say xx # of 30 packs. BTW I hope you are right and it is a huge multiple. I don't think that is the case based on previous gcan discussion, but it would be a welcomed fact if so.


Here's a refresher on what GCAN actually said. Now let's hear what you "thought" GCAN said.

"The company has been exploring options for large scale manufacturing. Our current manufacturing capabilities are limited to less than 10,000 units per month through our small-scale manufacturing facility and R&D lab in New Jersey. We have successfully identified and aligned ourselves with two contract manufacturing organizations (CMOs). These two companies have decades of experience with manufacturing our dosage forms for Rx products, and our team has worked with them in the past. They offer us cGMP manufacturing capabilities with the ability to produce millions of units per month. This is a critical milestone for the Company to be able to achieve market penetration through our partners’ distribution channels. For partner companies needing a THC product, we have aligned ourselves with two companies that manufacture the machinery required to produce our delivery system in our partners’ facilities as opposed to in our CMOs facilities. We believe with these two options available we can now advance our commercialization strategy and begin to take products out of the lab and into the hands of consumers."